Rapid Antigen Testing Market Share

North American Market Forecast

North America industry is anticipated to hold largest revenue share of 37% by 2037, rapid antigen testing market share due to the increasing prevalence of antibiotic-resistant infections and respiratory illnesses, the market is growing. According to a conservative estimate from the US Centers for Disease Control and Prevention (CDC), at least 23,000 Americans lose their lives to antibiotic-resistant diseases each year, impacting over two million individuals annually.

Additionally, the regional governments have put laws and programs into place to encourage the adoption of fast antigen testing. This entails supplying funds, increasing the number of tests available, and utilizing these tests in public health plans. Furthermore, the rapid antigen testing market for rapid antigen testing is expanding more quickly due to the existence of significant players like Abbott Laboratories, Quidel Corporation, and Roche Diagnostics.

APAC Market Statistics

By 2037, Asia Pacific region in rapid antigen testing market is anticipated to capture over 28% revenue share due to rise in the number of infectious disease cases in the region is the reason for the growth. Additionally, governments are making significant investments in the healthcare sector, along with the people in the region are becoming more conscious of the necessity of quick antigen testing.

Furthermore, Asia-Pacific presents a profitable opportunity for businesses in the rapid testing sector because of its sizable population base and increasing level of disposable income. According to a report, the Asia and Pacific region is home to 60% of the world's population (4.3 billion people), including the world's most populated countries, China and India.